<!doctype html>
<html lang="en">

<head>
    <title>aHUS Registry</title>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS v5.2.0-beta1 -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@5.2.0-beta1/dist/css/bootstrap.min.css" integrity="sha384-0evHe/X+R7YkIZDRvuzKMRqM+OrBnVFBL6DOitfPri4tjfHxaWutUpFmBp4vmVor" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.typekit.net/xqf5auy.css">
    <link rel="stylesheet" href="/css/styles.css">
</head>

<body>
    <!-- Header Start -->
    <header class="header sticky-top bg-white">
        <div class="container-fluid">
            <div class="nav-wrapper text-center">
                <nav class="main-nav navbar navbar-expand-lg bg-white">
                    <div class="container text">
                        <a class="navbar-brand" href="#">
                            <img src="img/logo.jpg">
                        </a>
                        <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
            <span class="navbar-toggler-icon"></span>
            </button>
                        <div class="collapse navbar-collapse" id="navbarSupportedContent">
                            <ul class="navbar-nav me-auto mb-2 mb-lg-0">
                                <li class="nav-item">
                                    <a class="nav-link active" aria-current="page" href="#what">What is aHUS?</a>
                                </li>
                                <li class="nav-item">
                                    <a class="nav-link" href="#registry">aHUS Registry</a>
                                </li>
                                <li class="nav-item">
                                    <a class="nav-link" href="#patients">Patients Included</a>
                                </li>
                                <li class="nav-item">
                                    <a class="nav-link" href="#advisory">Scientific Advisory Board</a>
                                </li>
                                <li class="nav-item">
                                    <a class="nav-link" href="#library">Library</a>
                                </li>
                                <li class="nav-item">
                                    <a class="nav-link" href="#">SAB Docs</a>
                                </li>
                            </ul>
                        </div>
                    </div>
                    <a href="#">
                        <div class="contact-tag">
                            <div class="contact-tag-inner">
                                <div class="contact-tag-left">
                                    <p class="contact-tag-font-sm mb-0">Any questions?</p>
                                    <h5>Contact us</h5>
                                </div>
                                <div class="contact-tag-right">
                                    <svg xmlns="http://www.w3.org/2000/svg" width="36" height="36" fill="currentColor" class="bi bi-envelope" viewBox="0 0 16 16">
                                <path d="M0 4a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v8a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V4Zm2-1a1 1 0 0 0-1 1v.217l7 4.2 7-4.2V4a1 1 0 0 0-1-1H2Zm13 2.383-4.708 2.825L15 11.105V5.383Zm-.034 6.876-5.64-3.471L8 9.583l-1.326-.795-5.64 3.47A1 1 0 0 0 2 13h12a1 1 0 0 0 .966-.741ZM1 11.105l4.708-2.897L1 5.383v5.722Z"/>
                              </svg>
                                </div>
                            </div>
                        </div>
                    </a>
                </nav>
            </div>
        </div>
    </header>
    <!-- Header End -->

    <!-- Masthead Start -->
    <div class="masthead mb-3">
        <div class="color-overlay d-flex align-items-center">
            <div class="container">
                <div class="row">
                    <div class="col-12 contact-tag-mobile-wrapper">
                        <h1>Welcome to the aHUS Registry</h1>
                        <a href="#">
                            <div class="contact-tag-mobile">
                                <div class="contact-tag-mobile-inner">
                                    <div class="contact-tag-mobile-left">
                                        <p class="contact-tag-mobile-font-sm mb-0">Any questions?</p>
                                        <h5>Contact us</h5>
                                    </div>
                                    <div class="contact-tag-mobile-right">
                                        <svg xmlns="http://www.w3.org/2000/svg" width="36" height="36" fill="currentColor" class="bi bi-envelope" viewBox="0 0 16 16">
                                    <path d="M0 4a2 2 0 0 1 2-2h12a2 2 0 0 1 2 2v8a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2V4Zm2-1a1 1 0 0 0-1 1v.217l7 4.2 7-4.2V4a1 1 0 0 0-1-1H2Zm13 2.383-4.708 2.825L15 11.105V5.383Zm-.034 6.876-5.64-3.471L8 9.583l-1.326-.795-5.64 3.47A1 1 0 0 0 2 13h12a1 1 0 0 0 .966-.741ZM1 11.105l4.708-2.897L1 5.383v5.722Z"/>
                                  </svg>
                                    </div>
                                </div>
                            </div>
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <!-- Masthead End -->

    <!-- What Section Start -->
    <div class="container" id="what">
        <div class="row">
            <div class="col-12">
                <h2 class="pb-5">What is aHUS?</h2>
            </div>
        </div>
    </div>

    <div class="container">
        <div class="row">
            <div class="col-12 col-md-7">
                <h4>Disease definition</h4>
                <ul>
                    <li>aHUS is a chronic and progressive disease. It is characterized by the development of TMA, which leads to systemic organ failure<sup>1</sup></li>
                    <li>TMA comprises thrombosis, inflammation, and occlusion of microvasculature throughout the body, leading to ischemia and organ failure<sup>1</sup></li>
                    <li>TMA is defined by its clinical characteristics<sup>1</sup></li>
                    <ul>
                        <li>Decreased platelet count</li>
                        <li>Evidence of organ impairment/damage (e.g. serum creatinine > upper limit of normal (ULN))</li>
                        <li>Evidence off microangiopathic hemolysis (e.g. raised lactate dehydrogenase (LDH), decreased haptoglobin, schistocytes)</li>
                    </ul>
                    <li>30-40% of patients progress to end-stage renal disease (ESRD) or die with the first clinical manifestation despite plasma exchange or plasma infusion (PE/PI)<sup>2,3</sup></li>
                    <li>65% of all patients die, require dialysis, or have permanent renal damage within the first year after diagnosis despite plasma exchange/plasma infusion (PE/PI)<sup>2</sup></li>
                </ul>
                <div class="legal">
                    <ol>
                        <li>Schmidtko J et al. Am J Kidney Dis 2013: 61: 289-299.</li>
                        <li>Caprioli J et al. Blood 2006; 108: 1267-1279.</li>
                        <li>Noris M et al. Clin J Am Soc Nephrol 2010;5:1844-1859.</li>
                    </ol>
                </div>
            </div>
            <div class="col-12 col-md-5">
                <div class="callout rounded-3">
                    <h5>Incidence and prevalance of the disease</h5>
                    <ul>
                        <li>Incidence and prevalence<sup>1,2</sup></li>
                        <ul>
                            <li>Very few sources of data are available regarding the incidence and prevalence of aHUS<sup>1</sup></li>
                            <li>Incidence: 0.11-2 cases/million (as estimated in Europe and the United States)<sup>1</sup>/li>
                                <li>Prevalence: up to 33 cases/million/year (as estimated in Europe)<sup>1</sup></li>
                                <li>At least 50% of patients have underlying inherited and/or acquired complement abnormality<sup>2</sup></li>
                                <li>Gender distribution is similar (slight predominance in females when the disease appears later in life)<sup>1</sup></li>
                        </ul>
                    </ul>
                </div>
                <div class="legal">
                    <ol>
                        <li>Campistol JM, et al. Nefrologia. 2015;C5(2S:421-447</li>
                        <li>GooKship THJ, et al. KiKney mnternational. 2017;91: 5C9-55</li>
                    </ol>
                </div>
            </div>
        </div>
    </div>
    <!-- What Section End -->

    <!-- Chart Start -->
    <div class="container container-narrow my-4 pt-5">
        <div class="row">
            <div class="col-12">
                <h4>Diagnosis</h4>
                <div class="text-center">
                    <img src="img/chart.png" class="img-fluid" style="width:100%" />
                </div>
                <div class="pt-5">
                    <p>Laurence J et al. Clinical Advances in Hematology & Oncology. 2016; 14(11) Sup11. 1-15</p>
                    <p>Acronyms</p>
                    <ul class="list-unstyled">
                        <li class="list-group-item">TMA &mdash; Thrombotic microangiopathy</li>
                        <li class="list-group-item">aHUS &mdash; atypical Hemolytic Uremic SynKrome</li>
                        <li class="list-group-item">TTP &mdash; Thrombotic thrombocytopenic purpura </li>
                        <li class="list-group-item">STEC-HUS - Shiga toxin-proKucing Escherichia coli &mdash; Hemolytic Uremic SynKrome</li>
                    </ul>
                </div>
            </div>
        </div>
    </div>
    <!-- Chart End -->

    <!-- Registry Start -->
    <div class="container-fluid teal" id="registry">
        <div class="container">
            <div class="row">
                <div class="col-12">
                    <h3 class="py-5">What is the aHUS directory?<sup>1</sup></h3>
                    <ul>
                        <li>The global aHUS patient registry (US National mnstitutes of Health ClinicalTrials.gov identifier: NCT0152218CS) was initiated in April 2012 to prospectively capture postmarketing effectiveness and safety data on patients with aHUS;
                            the registry will record information on the progression of disease in all aHUS patients.</li>
                        <li>The Registry fulfills postmarketing regulatory requirements by providing follow up on patients with aHUS.</li>
                        <li>Successful registry implementation is contingent on contributions from both academia and Alexion.</li>
                        <ul>
                            <li>Academia provides access to global, longitudinal data and increased scientific knowledge to better manage Patients.</li>
                            <li>Alexion fosters relationships with academic partners, building credibility and scientific integrity, while also providing transparency and clear guidelines for publication.</li>
                        </ul>
                        <li>A single, global aHUS patient registry can maximize both physician and patient participation to best capture information on disease, safety, and efficacy data in a population with a very rare disease.</li>
                    </ul>
                    <p>The aHUS Registry is currently being implemented in the following countries:</p>
                    </ul>
                </div>
            </div>
        </div>
    </div>

    <div class="container-fluid teal-dark py-5">
        <div class="container">
            <div class="row">
                <div class="col-12 table-responsive">
                    <table class="table text-white">
                        <tbody>
                            <tr>
                                <td>Australia</td>
                                <td>Denmark</td>
                                <td>Italy</td>
                                <td>Spain</td>
                                <td>United Arab Emirates</td>
                            </tr>
                            <tr>
                                <td>Austria</td>
                                <td>Finland</td>
                                <td>Norway</td>
                                <td>Sweden</td>
                                <td>United Kingdom</td>
                            </tr>
                            <tr>
                                <td>Belgium</td>
                                <td>France</td>
                                <td>Poland</td>
                                <td>Switzerland</td>
                                <td>United States</td>
                            </tr>
                            <tr>
                                <td>Canada</td>
                                <td>Germany</td>
                                <td>Russia</td>
                                <td>Taiwan</td>
                                <td></td>
                            </tr>
                            <tr>
                                <td>Czech Republic</td>
                                <td>Israel</td>
                                <td>South Korea</td>
                                <td>Turkey</td>
                                <td></td>
                            </tr>
                        </tbody>
                    </table>
                    </ul>
                </div>
            </div>
        </div>
    </div>
    <!-- Registry End -->

    <!-- Patients Start -->
    <div class="container" id="patients">
        <div class="row">
            <div class="col-12">
                <h2>Which patients can be included?</h2>
            </div>
        </div>
    </div>
    <div class="container">
        <div class="row">
            <div class="col-12">
                <p>Inclusion Criteria</p>
                <ul>
                    <li>Male or female patients of any age, including minors, who have been diagnosed with aHUD</li>
                    <li>Diagnosis of aHUS includes:</li>
                    <ul>
                        <li>Clinical diagnosis of aHUS</li>
                        <li>Patients with or without an identified complement regulatory factor genetic abnormality or anti-complement factor antibody</li>
                        <li>ADAMTS13 > 5% (if performed)</li>
                    </ul>
                    <li>Able to give written informed consent. Patient or patient's parent/legal guardian must be willing and able to give written informed consent and the patient (if minor) must be willing to give written informed consent [if applicable
                        as determined by the central Institutional Review Boards/Independent Ethics Committees (IRB/IEC)]</li>
                </ul>
                <p>Exclusion Criteria</p>
                <ul>
                    <li>Hemolytic Uremic Syndrome (HUS) only due to Shiga Toxin</li>
                </ul>
            </div>
        </div>
    </div>
    <!-- Patients End -->

    <!-- Map Start -->
    <div class="container">
        <div class="row">
            <div class="col-12 py-5">
                <img src="/img/map.jpeg" class="img-fluid">
            </div>
        </div>
    </div>
    <!-- Map End -->

    <!-- Advisory Start -->
    <div class="advisory mb-5" id="advisory">
        <div class="d-flex align-items-center">
            <div class="container ">
                <div class="row">
                    <div class="col-12">
                        <h2>Scientific Advisory Board<sup>1</sup></h2>
                        <h5>Members of the Scientific Advisory Board</h5>
                        <h5>As of September 2018, the membership includes</h5>
                        <table class="table">
                            <tbody>
                                <tr>
                                    <th>Name</th>
                                    <th>Country</th>
                                    <th>Institution</th>
                                </tr>
                                <tr>
                                    <td>Christoph Licht</td>
                                    <td>Canada (Chair)</td>
                                    <td>The Hospital for Sick Children and University of Toronto</td>
                                </tr>
                                <tr>
                                    <td>Gema Ariceta</td>
                                    <td>Spain</td>
                                    <td>Hospital Valle d'Hebron, Barcelona</td>
                                </tr>
                                <tr>
                                    <td>Gianluigi Ardissino</td>
                                    <td>Italy</td>
                                    <td>Fondazione IRCCS Cà Granda, Ospedale<br><em>Maggiore Policlinico, Milan</em></td>
                                </tr>
                                <tr>
                                    <td>David Cohen</td>
                                    <td>US</td>
                                    <td>Columbia University, New York</td>
                                </tr>
                                <tr>
                                    <td>Fadi Fakhouri</td>
                                    <td>France</td>
                                    <td>CHU de Nantes-Hôpital Hotel Dieu, Nantes</td>
                                </tr>
                                <tr>
                                    <td>VéWonique FWémeaux-Bacchi </td>
                                    <td>France</td>
                                    <td>(Co-chair) Hôpital Européen Georges Pompidou, <em>Paris</em></td>
                                </tr>
                                <tr>
                                    <td>Larry Greenbaum</td>
                                    <td>US</td>
                                    <td>Emory University, Atlanta</td>
                                </tr>
                                <tr>
                                    <td>Nicole Isbel</td>
                                    <td>Australia</td>
                                    <td>Princess Alexandra Hospital, Brisbane</td>
                                </tr>
                                <tr>
                                    <td>Sally Johnson</td>
                                    <td>UK</td>
                                    <td>Newcastle Upon Tyne Hospital, Newcastle</td>
                                </tr>
                                <tr>
                                    <td>Frank Schaefer</td>
                                    <td>Germany</td>
                                    <td>University Clinic Pediatric Nephrology, Heidelberg</td>
                                </tr>
                                <tr>
                                    <td>Marie Ann Scully</td>
                                    <td>UK</td>
                                    <td>University College London Hospitals NHS Foundation Trust, London</td>
                                </tr>
                                <tr>
                                    <td>Johan VanLe Walle</td>
                                    <td>Belgium</td>
                                    <td>UZ Gent Dienst Nefrologie, Gent</td>
                                </tr>
                                <tr>
                                    <td>Leonard Woodward</td>
                                    <td>UK</td>
                                    <td>aHUS Alliance (Patient Advocate)</td>
                                </tr>
                                <tr>
                                    <td>Benjamin Miller</td>
                                    <td>US</td>
                                    <td>Alexion Pharmaceuticals, Inc.</td>
                                </tr>
                            </tbody>
                        </table>
                        <ul>
                            <li>The registry is supported by Alexion Pharmaceuticals, Inc., with governance by an independent scientific advisory board (SAB) and national coordinators representing each participating country.</li>
                            <li>Some key responsibilities of the SAB are to:</li>
                            <ul>
                                <li>Provide scientific advice on aHUS registry-related matters.</li>
                                <li>Propose, discuss, and evaluate program objectives with Alexion.</li>
                                <li>Review and provide guidance on future amendments to the protocol, data variables to be collected, and case report refinements (all as appropriate).</li>
                                <li>Provide ad hoc review of documents and periodic phone/email consultation.</li>
                                <li>Advise on analyses and scientific questions of interest.</li>
                                <li>Review and provide feedback on publication goals and logistics.</li>
                                <li>Contribute to the development of the publication plan.</li>
                                <li>Establish and follow protocols for the review and approval of external requests for analyses and publications from individual investigators or national coordinators.</li>
                                <li>Advise, counsel, and guide individuals on publications that utilize aHUS registry data and resources and/or use the aHUS registry name.</li>
                                <li>Review publication drafts before submission to journals or public release.</li>
                            </ul>
                        </ul>
                        <p>Exclusion Criteria</p>
                        <ul>
                            <li>Hemolytic Uremic Syndrome (HUS) only due to Shiga Toxin</li>
                        </ul>
                        <h5>1. Licht et al. BMC Nephrology (2015) 16:207.</h5>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <!-- Advisory End -->

    <!-- Library Start -->
    <div class="library mb-0" id="library">
        <div class="align-items-center">
            <div class="container ">
                <div class="row">
                    <div class="col-12">
                        <h2>Library</h2>
                        <table class="table">
                            <tbody>
                                <tr>
                                    <th>Document</th>
                                    <th>Download</th>
                                </tr>
                                <tr>
                                    <td>aHUS Registry Slide Deck</td>
                                    <td><a href=""><svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-download" viewBox="0 0 16 16">
                                        <path d="M.5 9.9a.5.5 0 0 1 .5.5v2.5a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1v-2.5a.5.5 0 0 1 1 0v2.5a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2v-2.5a.5.5 0 0 1 .5-.5z"/>
                                        <path d="M7.646 11.854a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V1.5a.5.5 0 0 0-1 0v8.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3z"/>
                                      </svg></a></td>
                                </tr>
                                <tr>
                                    <td>Publications</td>
                                    <td><a href=""><svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-download" viewBox="0 0 16 16">
                                        <path d="M.5 9.9a.5.5 0 0 1 .5.5v2.5a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1v-2.5a.5.5 0 0 1 1 0v2.5a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2v-2.5a.5.5 0 0 1 .5-.5z"/>
                                        <path d="M7.646 11.854a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V1.5a.5.5 0 0 0-1 0v8.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3z"/>
                                      </svg></a></td>
                                </tr>
                                <tr>
                                    <td>aHUS Registry SAB Charter</td>
                                    <td><a href=""><svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-download" viewBox="0 0 16 16">
                                        <path d="M.5 9.9a.5.5 0 0 1 .5.5v2.5a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1v-2.5a.5.5 0 0 1 1 0v2.5a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2v-2.5a.5.5 0 0 1 .5-.5z"/>
                                        <path d="M7.646 11.854a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V1.5a.5.5 0 0 0-1 0v8.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3z"/>
                                      </svg></a></td>
                                </tr>
                                <tr>
                                    <td>aHUS Registry National Coordinator Charter</td>
                                    <td><a href=""><svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-download" viewBox="0 0 16 16">
                                        <path d="M.5 9.9a.5.5 0 0 1 .5.5v2.5a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1v-2.5a.5.5 0 0 1 1 0v2.5a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2v-2.5a.5.5 0 0 1 .5-.5z"/>
                                        <path d="M7.646 11.854a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V1.5a.5.5 0 0 0-1 0v8.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3z"/>
                                      </svg></a></td>
                                </tr>
                                <tr>
                                    <td>Manuscript Authorship Criteria Process</td>
                                    <td><a href=""><svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-download" viewBox="0 0 16 16">
                                        <path d="M.5 9.9a.5.5 0 0 1 .5.5v2.5a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1v-2.5a.5.5 0 0 1 1 0v2.5a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2v-2.5a.5.5 0 0 1 .5-.5z"/>
                                        <path d="M7.646 11.854a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V1.5a.5.5 0 0 0-1 0v8.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3z"/>
                                      </svg></a></td>
                                </tr>
                                <tr>
                                    <td>aHUS Registry Concept Sheet template</td>
                                    <td><a href=""><svg xmlns="http://www.w3.org/2000/svg" width="32" height="32" fill="currentColor" class="bi bi-download" viewBox="0 0 16 16">
                                        <path d="M.5 9.9a.5.5 0 0 1 .5.5v2.5a1 1 0 0 0 1 1h12a1 1 0 0 0 1-1v-2.5a.5.5 0 0 1 1 0v2.5a2 2 0 0 1-2 2H2a2 2 0 0 1-2-2v-2.5a.5.5 0 0 1 .5-.5z"/>
                                        <path d="M7.646 11.854a.5.5 0 0 0 .708 0l3-3a.5.5 0 0 0-.708-.708L8.5 10.293V1.5a.5.5 0 0 0-1 0v8.793L5.354 8.146a.5.5 0 1 0-.708.708l3 3z"/>
                                      </svg></a></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
        </div>
    </div>
    <!-- Library End -->

    <!-- Footer Start-->
    <div class="container-fluid" id="footer">
        <div class="container">
            <footer class="py-4 mb-1">
                <ul class="nav pb-3 mb-3">
                    <li class="nav-item"><a href="#" class="nav-link px-2 text-muted" style="padding-left:0!important;">Site Map</a></li>
                    <li class="nav-item"><a href="#" class="nav-link px-2 text-muted">Legal</a></li>
                    <li class="nav-item"><a href="#" class="nav-link px-2 text-muted">SAB Documents</a></li>
                </ul>
                <p class="text-muted">Registry sponsored by Alexion Pharmaceuticals, Inc. | Revised on: 28th January 2022</p>
            </footer>
        </div>
    </div>
    <!-- Footer End -->

    <!-- Modal Start -->
    <!-- Button trigger modal start
    <button type="button" class="btn btn-primary btn-lg" data-bs-toggle="modal" data-bs-target="#modelId">
        Launch
    </button>
    Button trigger modal end -->

    <!-- Modal -->
    <div class="modal fade" id="modelId" tabindex="-1" role="dialog" aria-labelledby="modelTitleId" aria-hidden="true">
        <div class="modal-dialog" role="document">
            <div class="modal-content">
                <div class="modal-header">
                    <h5 class="modal-title">Modal title</h5>
                    <button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
                </div>
                <div class="modal-body">
                    Body
                </div>
                <div class="modal-footer">
                    <button type="button" class="btn btn-secondary" data-bs-dismiss="modal">Close</button>
                    <button type="button" class="btn btn-primary">Save</button>
                </div>
            </div>
        </div>
    </div>
    <!-- Modal End  -->

    <!-- Bootstrap JavaScript Libraries -->
    <script src="https://cdn.jsdelivr.net/npm/@popperjs/core@2.11.5/dist/umd/popper.min.js" integrity="sha384-Xe+8cL9oJa6tN/veChSP7q+mnSPaj5Bcu9mPX5F5xIGE0DVittaqT5lorf0EI7Vk" crossorigin="anonymous"></script>

    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.2.0-beta1/dist/js/bootstrap.min.js" integrity="sha384-kjU+l4N0Yf4ZOJErLsIcvOU2qSb74wXpOhqTvwVx3OElZRweTnQ6d31fXEoRD1Jy" crossorigin="anonymous"></script>

    <script src="/js/scripts.js"></script>

</body>

</html>